Drug · DIN 02231083 · Veterinary
DECTOMAX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 13, 2015; first marketed July 25, 1997.
- Drug Identification Number (DIN)
- 02231083
- Company (DIN owner)
- Zoetis Canada IncKirkland, Quebec, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Solution
- Route
- Subcutaneous; Intramuscular
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DORAMECTIN | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 15, 2022: NOC 28400Supplement to a New Drug Submission (SNDS) · Addition of a drug product manufacturing site
- December 18, 2020: NOC 24827Supplement to a New Drug Submission (SNDS) · Change in formulation
- February 24, 2014: NOC 15305New Drug Submission (NDS) · Transfer of drug identification number (din) holder
- July 5, 2007: NOC 8886Supplement to a New Drug Submission (SNDS) · Alternate manufacturing site; change in packaging
- February 4, 1998: NOC 6713Supplement to a New Drug Submission (SNDS) · Additional claims
- April 14, 1997: NOC 6677New Drug Submission (NDS)
Other DINs named DECTOMAX
- DIN 02236566 · Cancelled Post Market